Reproductionresearch

Total Page:16

File Type:pdf, Size:1020Kb

Reproductionresearch REPRODUCTIONRESEARCH Actions of anti-Mu¨llerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition Eric Nilsson, Natalie Rogers and Michael K Skinner Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington 99164-4231, USA Correspondence should be addressed to M K Skinner; Email: [email protected] Abstract The oocytes found within the primordial follicles of mammalian ovaries remain quiescent for months to years until they receive the appropriate signals to undergo the primordial to primary follicle transition and initiate folliculogenesis. The molecular mechanisms and extracellular signaling factors that regulate this process remain to be fully elucidated. The current study investigates the mechanisms utilized by anti-Mu¨llerian hormone (AMH; i.e. Mu¨llerian inhibitory substance) to inhibit the primordial to primary follicle transition. Ovaries from 4-day-old rats were placed into organ culture and incubated in the absence or presence of AMH, either alone or in combination with known stimulators of follicle transition, including basic fibroblast growth factor (bFGF), kit ligand (KITL), or keratinocyte growth factor (KGF). Following 10 days of culture, the ovaries were sectioned, stained, and morphologically evaluated to determine the percentage of primordial versus developing follicles. As previously demonstrated, AMH treatment decreased primordial to primary follicle transition. Interestingly, AMH inhibited the stimulatory actions of KITL, bFGF, and KGF. Therefore, AMH can inhibit the basal and stimulated development of primordial follicles. To investigate the mechanism of AMH actions, the influence AMH has on the ovarian transcriptome was analyzed. AMH treatment when compared with controls was found to alter the expression of 707 genes. The overall effect of AMH exposure is to decrease the expression of stimulatory factors, increase the expression of inhibitory factors, and regulate cellular pathways (e.g. transforming growth factor b signaling pathway) that result in the inhibition of primordial follicle development. Analysis of the regulatory factors and cellular pathways altered by AMH provides a better understanding of the molecular control of primordial follicle development. Reproduction (2007) 134 209–221 Introduction of granulosa cells, a theca cell layer, and eventually a fluid-filled antrum. Once the primordial to primary follicle Primordial follicles in mammalian ovaries are composed transition is complete, the follicle will either continue to of an oocyte surrounded by squamous (i.e. flattened) pre- develop until the oocyte is ovulated or undergo atresia and granulosa cells. The oocytes in primordial follicles are regress (Peters et al. 1975, Cran & Moor 1980, Hirshfield arrested in the diplotene stage of prophase I of meiosis. 1991, Rajah et al. 1992). Primordial follicles gradually These arrested follicles remain quiescent for months or develop and leave the arrested pool over the course of a years until they receive the necessary signals to grow and female’s reproductive lifespan. Once the follicle pool is develop. The initiation of primordial follicle development depleted, reproduction ceases and women enter meno- is termed primordial to primary follicle transition. pause (Gosden et al. 1983, Richardson et al. 1987, Faddy Although recent studies have identified several factors et al. 1992, Faddy & Gosden 1996, Faddy 2000). The size of that regulate primordial to primary follicle transition the primordial follicle pool is fixed early in life (Hirshfield (Nilsson & Skinner 2001, Fortune 2003, Skinner 2005, 1991). Although recent studies speculate that new oocytes Visser & Themmen 2005), this vital process for mamma- might be formed in adulthood (Johnson et al. 2004, 2005), lian reproduction remains to be fully elucidated. the initial size of the primordial follicle pool is a major Primordial to primary follicle transition involves pre- determinant of reproductive lifespan (Hirshfield 1994). granulosa cells around the oocyte becoming cuboidal Primordial to primary follicle transition is regulated epithelial granulosa while the oocyte increases in by both inhibitory and stimulatory growth factors diameter. As the follicle grows, it gains successive layers acting locally in a paracrine and/or autocrine manner. q 2007 Society for Reproduction and Fertility DOI: 10.1530/REP-07-0119 ISSN 1470–1626 (paper) 1741–7899 (online) Online version via www.reproduction-online.org 210 E Nilsson and others The only two extracellular signaling molecules that have KITL acts to recruit thecal cells from surrounding ovarian been identified as inhibiting follicle transition are stroma during the primordial to primary follicle tran- anti-Mu¨llerian hormone (AMH; Durlinger et al. 1999, sition (Parrott & Skinner 2000). How KITL interacts with 2002b) and stromal-derived factor 1 (SDF1 or CXCl12; AMH to regulate primordial to primary follicle transition Holt et al. 2006). SDF1 is a member of the large family of is also examined in the current study. chemokine molecules and binds to the G-protein- Growth factors produced by the theca/interstitial cells coupled receptor CXCR4 (Feng et al. 1996). A recent that surround follicles and promote the primordial to study revealed that SDF1 is expressed in the oocytes of primary follicle transition include bone morphogenic primordial and primary follicles. Mouse ovaries cultured protein 4 (BMP4), BMP7 (Shimasaki et al. 1999, Lee et al. in the presence of SDF1 showed an increase in follicle 2001, Nilsson & Skinner 2003), and keratinocyte growth density and a decrease in follicle diameter compared factor (KGF or FGF7; Kezele et al. 2005a). KGF is with controls, suggesting an inhibition of primordial to produced by isolated precursor theca cells surrounding primary follicle transition (Holt et al. 2006). primordial and early stage developing follicles (Kezele AMH, also known as Mu¨llerian inhibitory substance, et al. 2005a). Ovaries in culture treated with KGF have is a member of the transforming growth factor b family of an increased expression of KITL mRNA. Conversely, growth factors and binds to AMH receptor 2 (AMHR2). cultured ovaries treated with KITL have increased KGF AMH was first known for its role in causing regression of expression, suggesting a positive feedback loop between the Mu¨llerian ducts during fetal development in the male these two growth factors to promote the primordial to (Lee & Donahoe 1993, Mishina et al. 1999). In females, primary follicle transition (Kezele et al. 2005a). The AMH is expressed postnatally by the granulosa cells of interaction of KGF with AMH to regulate primordial to developing follicles from the secondary stage to the early primary follicle transition is also examined in the current antral stage (Durlinger et al. 2002a, 2002b). It is thought study. that the AMH produced by these early stage developing The objective of the current study is to investigate the follicles acts locally on primordial follicles to inhibit mechanisms of AMH action to inhibit primordial to the primordial to primary follicle transition (Visser & primary follicle transition. The interactions between Themmen 2005). How AMH acts to inhibit primordial AMH and an oocyte-derived growth factor (bFGF), a follicle transition is unknown, and is the focus of the granulosa-derived growth factor (KITL), and a precursor current study. theca-derived growth factor (KGF) are examined in vitro. Several growth factors have been found to be In addition, the pattern of gene expression (i.e. produced by the different cell types of the developing transcriptome) in AMH-treated ovaries is examined primordial follicle that can stimulate the primordial to using a microarray analysis to gain insight into what primary follicle transition. Those stimulatory factors that signaling pathways might be involved in AMH regulation are expressed in the oocytes of developing early stage of primordial to primary follicle transition. Elucidation of follicles include platelet-derived growth factor (PDGF; the regulatory mechanisms involved in primordial Dube et al. 1998, Laitinen et al. 1998, Nilsson et al. follicle development will provide potential therapeutic 2006), and basic fibroblast growth factor (bFGF/FGF2; targets to manipulate the primordial follicle pool and van Wezel et al. 1995, Yamamoto et al. 1997, Nilsson treat disease states such as premature ovarian failure. et al. 2001a). PDGF appears to act on the adjacent granulosa and theca cells (Nilsson et al. 2006). Receptors for bFGF have been found on granulosa cells Materials and Methods and oocytes (Shikone et al. 1992, Wandji et al. 1992, Ben-Haroush et al. 2005). Basic FGF has been shown to Organ culture and treatments stimulate proliferation of granulosa and ovarian stromal Postnatal 4-day-old rat ovaries were dissected from cells, and increase the mRNA expression of another freshly euthanized Sprague–Dawley rat pups. All animal stimulatory growth factor kit ligand (KITL; Lavranos et al. protocols were approved by the Washington State 1994, Roberts & Ellis 1999, Nilsson et al. 2001a, Nilsson University Animal Care and Use Committee. Whole & Skinner 2004). How bFGF interacts with AMH to ovaries were cultured as previously described (Nilsson regulate primordial to primary follicle transition is et al. 2001a) on floating filters (0.4 mm Millicell-CM, investigated in the current study. Millipore, Bedford, MD, USA) in 0.5 ml Dulbecco’s Growth factors that are expressed by granulosa
Recommended publications
  • Evolutionary Origin of Bone Morphogenetic Protein 15 And
    Evolutionary origin of Bone Morphogenetic Protein 15 and growth and differentiation factor 9 and differential selective pressure between mono- and polyovulating species Olivier Monestier, Bertrand Servin, Sylvain Auclair, Thomas Bourquard, Anne Poupon, Géraldine Pascal, Stéphane Fabre To cite this version: Olivier Monestier, Bertrand Servin, Sylvain Auclair, Thomas Bourquard, Anne Poupon, et al.. Evo- lutionary origin of Bone Morphogenetic Protein 15 and growth and differentiation factor 9 and differ- ential selective pressure between mono- and polyovulating species. Biology of Reproduction, Society for the Study of Reproduction, 2014, 91 (4), pp.1-13. 10.1095/biolreprod.114.119735. hal-01129871 HAL Id: hal-01129871 https://hal.archives-ouvertes.fr/hal-01129871 Submitted on 27 May 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. BIOLOGY OF REPRODUCTION (2014) 91(4):83, 1–13 Published online before print 6 August 2014. DOI 10.1095/biolreprod.114.119735 Evolutionary Origin of Bone Morphogenetic Protein 15 and Growth and Differentiation Factor 9
    [Show full text]
  • Mouse GDF-8/Myostatin Propeptide Antibody
    Mouse GDF-8/Myostatin Propeptide Antibody Monoclonal Rat IgG2B Clone # 84231 Catalog Number: MAB7881 DESCRIPTION Species Reactivity Mouse Specificity Detects mouse GDF­8 propeptide in direct ELISAs and Western blots. In direct ELISAs, no cross­reactivity with recombinant mouse (rm) GDF­1 propeptide, rmGDF­3 propeptide, rmGDF­5, or rmGDF­6 is observed. Source Monoclonal Rat IgG2B Clone # 84231 Purification Protein A or G purified from hybridoma culture supernatant Immunogen Mouse myeloma cell line NS0­derived recombinant mouse GDF­8 Asn25­Ser376 Accession # O08689 Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details. *Small pack size (­SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. APPLICATIONS Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website. Recommended Sample Concentration Western Blot 1 µg/mL Recombinant Mouse GDF­8/Myostatin Propeptide (Catalog # 1539­PG) PREPARATION AND STORAGE Reconstitution Reconstitute at 0.5 mg/mL in sterile PBS. Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (­SP) is shipped with polar packs. Upon receipt, store it immediately at ­20 to ­70 °C Stability & Storage Use a manual defrost freezer and avoid repeated freeze­thaw cycles. l 12 months from date of receipt, ­20 to ­70 °C as supplied. l 1 month, 2 to 8 °C under sterile conditions after reconstitution. l 6 months, ­20 to ­70 °C under sterile conditions after reconstitution.
    [Show full text]
  • Amh) Relative to Sox9a, Sox9b, and Cyp19a1a, During Gonad Development
    Gene Expression Patterns 5 (2005) 655–667 www.elsevier.com/locate/modgep Characterization and expression pattern of zebrafish anti-Mu¨llerian hormone (amh) relative to sox9a, sox9b, and cyp19a1a, during gonad development Adriana Rodrı´guez-Marı´, Yi-Lin Yan, Ruth A. BreMiller, Catherine Wilson, Cristian Can˜estro, John H. Postlethwait* Institute of Neuroscience, University of Oregon, 1425 E. 13th Avenue, Eugene, OR 97403, USA Received 28 January 2005; received in revised form 28 February 2005; accepted 28 February 2005 Available online 19 April 2005 Abstract The role of Anti-Mu¨llerian hormone (Amh) during gonad development has been studied extensively in mammals, but is less well understood in other vertebrates. In male mammalian embryos, Sox9 activates expression of Amh, which initiates the regression of the Mu¨llerian ducts and inhibits the expression of aromatase (Cyp19a1), the enzyme that converts androgens to estrogens. To better understand shared features of vertebrate gonadogenesis, we cloned amh cDNA from zebrafish, characterized its genomic structure, mapped it, analyzed conserved syntenies, studied its expression pattern in embryos, larvae, juveniles, and adults, and compared it to the expression patterns of sox9a, sox9b and cyp19a1a. We found that the onset of amh expression occurred while gonads were still undifferentiated and sox9a and cyp19a1a were already expressed. In differentiated gonads of juveniles, amh showed a sexually dimorphic expression pattern. In 31 days post-fertilization juveniles, testes expressed amh and sox9a, but not cyp19a1a, while ovaries expressed cyp19a1a and sox9b, but not amh.In adult testes, amh and sox9a were expressed in presumptive Sertoli cells. In adult ovaries, amh and cyp19a1a were expressed in granulosa cells surrounding the oocytes, and sox9b was expressed in a complementary fashion in the ooplasm of oocytes.
    [Show full text]
  • Dendrite Complexity of Sympathetic Neurons Is Controlled During Postnatal Development by BMP Signaling
    15132 • The Journal of Neuroscience, September 18, 2013 • 33(38):15132–15144 Development/Plasticity/Repair Dendrite Complexity of Sympathetic Neurons Is Controlled during Postnatal Development by BMP Signaling Afsaneh Majdazari,1 Jutta Stubbusch,1 Christian M. Mu¨ller,2 Melanie Hennchen,1 Marlen Weber,1 Chu-Xia Deng,3 Yuji Mishina,4 Gu¨nther Schu¨tz,5 Thomas Deller,2 and Hermann Rohrer1 1Reseach Group Developmental Neurobiology, Max-Planck-Institute for Brain Research, Frankfurt/M, Germany, 2Institute of Clinical Neuroanatomy, Neuroscience Center, Goethe-University Frankfurt, Frankfurt/M, Germany, 3Genetics of Development and Disease Branch, NIDDK, NIH, Bethesda, Maryland 20892, 4Department of Biologic and Materials Sciences, University of Michigan, School of Dentistry, Ann Arbor, Michigan 48109-1078, and 5Department Molecular Biology of the Cell I German Cancer Research Center, D-69120 Heidelberg, Germany Dendrite development is controlled by the interplay of intrinsic and extrinsic signals affecting initiation, growth, and maintenance of complex dendrites. Bone morphogenetic proteins (BMPs) stimulate dendrite growth in cultures of sympathetic, cortical, and hippocam- pal neurons but it was unclear whether BMPs control dendrite morphology in vivo. Using a conditional knock-out strategy to eliminate Bmpr1a and Smad4 in immature noradrenergic sympathetic neurons we now show that dendrite length, complexity, and neuron cell body size are reduced in adult mice deficient of Bmpr1a. The combined deletion of Bmpr1a and Bmpr1b causes no further decrease in dendritic features. Sympathetic neurons devoid of Bmpr1a/1b display normal Smad1/5/8 phosphorylation, which suggests that Smad- independent signaling paths are involved in dendritic growth control downstream of BMPR1A/B. Indeed, in the Smad4 conditional knock-out dendrite and cell body size are not affected and dendrite complexity and number are increased.
    [Show full text]
  • GDF1 Is a Novel Mediator of Macrophage Infiltration in Brown
    Biochemistry and Biophysics Reports 5 (2016) 216–223 Contents lists available at ScienceDirect Biochemistry and Biophysics Reports journal homepage: www.elsevier.com/locate/bbrep GDF1 is a novel mediator of macrophage infiltration in brown adipose tissue of obese mice Yuki Onishi 1, Kazuya Fukasawa 1, Kakeru Ozaki, Takashi Iezaki, Yukio Yoneda, Eiichi Hinoi n Laboratory of Molecular Pharmacology, Division of Pharmaceutical Sciences, Kanazawa University Graduate School, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan article info abstract Article history: We previously demonstrated a marked upregulation in the bone morphogenic protein (BMP)/growth Received 8 October 2015 differentiation factor (GDF) family member, GDF5, which is capable of promoting brown adipogenesis, in Received in revised form brown adipose tissue (BAT) of obese mice. In this study, we identified other GDF family members, besides 27 November 2015 GDF5 that are responsive to different obesogenic signals in BAT using inborn and acquired obesity animal Accepted 18 December 2015 models. In BAT from leptin-deficient ob/ob mice, GDF1 expression was preferentially downregulated, Available online 21 December 2015 whereas the expression of several other genes in the BMP/GDF family, including GDF5, was upregulated. Keywords: Moreover, in cultured brown adipocytes exposed to tunicamycin and hydrogen peroxide, at concentra- BMP/GDF tions not affecting cellular viability, GDF1 expression was significantly downregulated. Recombinant Brown adipose tissue GDF1 failed to significantly alter brown adipogenesis, despite the promoted phosphorylation of Smad1/5/ Obesity 8 in cultured brown adipocytes, but accelerated Smad1/5/8 phosphorylation with a concomitant increase Macrophage in the number of migrating cells during exposure in a manner sensitive to activin-like kinase inhibitors in macrophagic RAW264.7 cells.
    [Show full text]
  • The Nuclear Receptor REVERB Represses the Transcription of Growthdifferentiation Factor 10 and 15 Genes in Rat Endometrium Strom
    Physiological Reports ISSN 2051-817X ORIGINAL RESEARCH The nuclear receptor REV-ERBa represses the transcription of growth/differentiation factor 10 and 15 genes in rat endometrium stromal cells Lijia Zhao1, Keishiro Isayama1, Huatao Chen1,*, Nobuhiko Yamauchi1, Yasufumi Shigeyoshi2, Seiichi Hashimoto3 & Masa-aki Hattori1 1 Department of Animal and Marine Bioresource Sciences, Graduate School of Agriculture, Kyushu University, Fukuoka, Japan 2 Department of Anatomy and Neurobiology, Kinki University School of Medicine, Osaka, Japan 3 Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Keywords Abstract Circadian clock, decidualization, growth/ differentiation factors, REV-ERBa. Cellular oscillators in the uterus play critical roles in the gestation processes of mammals through entraining of the clock proteins to numerous downstream Correspondence genes, including growth/differentiation factor (Gdf)10 and Gdf15. The expres- Masa-aki Hattori, Department of Animal and sion of Gdf10 and Gdf15 is significantly increased in the uterus during decidu- Marine Bioresource Sciences, Graduate alization, but the mechanism underlying the regulation of Gdf gene expression School of Agriculture, Kyushu University, in the uterus is poorly understood. Here, we focused on the function of the Hakozaki, Higashi-ku, Fukuoka 812-8581, cellular oscillators in the expression of Gdf family by using uterine endome- Japan. Tel: +81-92-642-2938 trial stromal cells (UESCs) isolated from pregnant Per2-dLuc transgenic rats. Fax: +81-92-642-2938 A significant decline of Per2-dLuc bioluminescence activity was induced in E-mail: [email protected] in vitro decidualized UESCs, and concomitantly the expression of canonical clock genes was downregulated. Conversely, the expression of Gdf10 and ⁄ Present address Gdf15 of the Gdf was upregulated.
    [Show full text]
  • Vg1-Nodal Heterodimers Are the Endogenous Inducers of Mesendoderm Tessa G Montague1*, Alexander F Schier1,2,3,4,5*
    RESEARCH ARTICLE Vg1-Nodal heterodimers are the endogenous inducers of mesendoderm Tessa G Montague1*, Alexander F Schier1,2,3,4,5* 1Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States; 2Center for Brain Science, Harvard University, Cambridge, United States; 3Broad Institute of MIT and Harvard, Cambridge, United States; 4Harvard Stem Cell Institute, Cambridge, United States; 5FAS Center for Systems Biology, Harvard University, Cambridge, United States Abstract Nodal is considered the key inducer of mesendoderm in vertebrate embryos and embryonic stem cells. Other TGF-beta-related signals, such as Vg1/Dvr1/Gdf3, have also been implicated in this process but their roles have been unclear or controversial. Here we report that zebrafish embryos without maternally provided vg1 fail to form endoderm and head and trunk mesoderm, and closely resemble nodal loss-of-function mutants. Although Nodal is processed and secreted without Vg1, it requires Vg1 for its endogenous activity. Conversely, Vg1 is unprocessed and resides in the endoplasmic reticulum without Nodal, and is only secreted, processed and active in the presence of Nodal. Co-expression of Nodal and Vg1 results in heterodimer formation and mesendoderm induction. Thus, mesendoderm induction relies on the combination of two TGF-beta- related signals: maternal and ubiquitous Vg1, and zygotic and localized Nodal. Modeling reveals that the pool of maternal Vg1 enables rapid signaling at low concentrations of zygotic Nodal. DOI: https://doi.org/10.7554/eLife.28183.001 Introduction *For correspondence: tessa. [email protected] (TGM); The induction of mesoderm and endoderm (mesendoderm) during embryogenesis and embryonic [email protected] (AFS) stem cell differentiation generates the precursors of the heart, liver, gut, pancreas, kidney and other internal organs.
    [Show full text]
  • 6 Signaling and BMP Antagonist Noggin in Prostate Cancer
    [CANCER RESEARCH 64, 8276–8284, November 15, 2004] Bone Morphogenetic Protein (BMP)-6 Signaling and BMP Antagonist Noggin in Prostate Cancer Dominik R. Haudenschild, Sabrina M. Palmer, Timothy A. Moseley, Zongbing You, and A. Hari Reddi Center for Tissue Regeneration and Repair, Department of Orthopedic Surgery, School of Medicine, University of California, Davis, Sacramento, California ABSTRACT antagonists has recently been discovered. These are secreted proteins that bind to BMPs and reduce their bioavailability for interactions It has been proposed that the osteoblastic nature of prostate cancer with the BMP receptors. Extracellular BMP antagonists include nog- skeletal metastases is due in part to elevated activity of bone morphoge- gin, follistatin, sclerostatin, chordin, DCR, BMPMER, cerberus, netic proteins (BMPs). BMPs are osteoinductive morphogens, and ele- vated expression of BMP-6 correlates with skeletal metastases of prostate gremlin, DAN, and others (refs. 11–16; reviewed in ref. 17). There are cancer. In this study, we investigated the expression levels of BMPs and several type I and type II receptors that bind to BMPs with different their modulators in prostate, using microarray analysis of cell cultures affinities. BMP activity is also regulated at the cell membrane level by and gene expression. Addition of exogenous BMP-6 to DU-145 prostate receptor antagonists such as BAMBI (18), which acts as a kinase- cancer cell cultures inhibited their growth by up-regulation of several deficient receptor. Intracellularly, the regulation of BMP activity at cyclin-dependent kinase inhibitors such as p21/CIP, p18, and p19. Expres- the signal transduction level is even more complex. There are inhib- sion of noggin, a BMP antagonist, was significantly up-regulated by itory Smads (Smad-6 and Smad-7), as well as inhibitors of inhibitory BMP-6 by microarray analysis and was confirmed by quantitative reverse Smads (AMSH and Arkadia).
    [Show full text]
  • GDF1 Antibody Cat
    GDF1 Antibody Cat. No.: 7093 GDF1 Antibody Immunofluorescence of GDF1 in human lung tissue with GDF1 antibody at 20 μg/mL. Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse, Rat Rabbit polyclonal GDF1 antibody was raised against a 16 amino acid peptide near the amino terminus of human GDF1. IMMUNOGEN: The immunogen is located within amino acids 30 - 80 of GDF1. TESTED APPLICATIONS: ELISA, IF, WB GDF1 antibody can be used for detection of GDF1 by Western blot at 1 - 2 μg/mL. For immunofluorescence start at 20 μg/mL. APPLICATIONS: Antibody validated: Western Blot in rat samples and Immunofluorescence in human samples. All other applications and species not yet tested. September 24, 2021 1 https://www.prosci-inc.com/gdf1-antibody-7093.html GDF1 antibody is predicted to not cross-react with any other members of the growth SPECIFICITY: differentiation factor family. POSITIVE CONTROL: 1) Cat. No. 1462 - Rat Lung Tissue Lysate 2) Cat. No. 10-101 - Human Lung Tissue Slide PREDICTED MOLECULAR 41 kDa WEIGHT: Properties PURIFICATION: GDF1 Antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: GDF1 Antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/mL GDF1 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one STORAGE CONDITIONS: year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. Additional Info OFFICIAL SYMBOL: GDF1 ALTERNATE NAMES: GDF1 Antibody: RAI, DORV, DTGA3GDF-1 ACCESSION NO.: NP_001483 PROTEIN GI NO.: 110349792 GENE ID: 2657 USER NOTE: Optimal dilutions for each application to be determined by the researcher.
    [Show full text]
  • Context-Dependent Roles in Cell and Tissue Physiology
    Downloaded from http://cshperspectives.cshlp.org/ on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press TGF-b and the TGF-b Family: Context-Dependent Roles in Cell and Tissue Physiology Masato Morikawa,1 Rik Derynck,2 and Kohei Miyazono3 1Ludwig Cancer Research, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24 Uppsala, Sweden 2Department of Cell and Tissue Biology, University of California at San Francisco, San Francisco, California 94143 3Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan Correspondence: [email protected] The transforming growth factor-b (TGF-b) is the prototype of the TGF-b family of growth and differentiation factors, which is encoded by 33 genes in mammals and comprises homo- and heterodimers. This review introduces the reader to the TGF-b family with its complexity of names and biological activities. It also introduces TGF-b as the best-studied factor among the TGF-b family proteins, with its diversity of roles in the control of cell proliferation and differentiation, wound healing and immune system, and its key roles in pathology, for exam- ple, skeletal diseases, fibrosis, and cancer. lthough initially thought to stimulate cell TGF-b has been well documented in most cell Aproliferation, just like many growth factors, types, and has been best characterized in epithe- it became rapidly accepted that transforming lial cells. The bifunctional and context-depen- growth factor b (TGF-b) is a bifunctional reg- dent nature of TGF-b activities was further con- ulator that either inhibits or stimulates cell pro- firmed in a large variety of cell systems and liferation.
    [Show full text]
  • Identification of QTL That Interact with Myostatin Genotype in C57BL/6 X M16i Mice Ye Cheng Iowa State University
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2011 Identification of QTL that Interact with Myostatin Genotype in C57BL/6 x M16i Mice Ye Cheng Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Animal Sciences Commons Recommended Citation Cheng, Ye, "Identification of QTL that Interact with Myostatin Genotype in C57BL/6 x M16i Mice" (2011). Graduate Theses and Dissertations. 11933. https://lib.dr.iastate.edu/etd/11933 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Identification of QTL that interact with myostatin genotype in C57BL/6 x M16i mice by Ye Cheng A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Genetics Program of Study Committee: James M. Reecy, Major Professor Jack C. Dekkers Kristen M. Johansen Elisabeth J. Lonergan Daniel S. Nettleton Iowa State University Ames, Iowa 2011 Copyright © Ye Cheng, 2011. All rights reserved. ii DEDICATION I would like to dedicate this thesis to my husband Su Chang and to my parents Huaqing Cheng and Peihua Dong, without whose support I would not have been able to complete this work. iii TABLE OF CONTENTS ACKNOWLEDGEMENTS v ABSTRACT vii CHAPTER 1. GENERAL INTRODUCTION 1 Introduction 1 Thesis Organization 3 Literature Review 4 References 32 CHAPTER 2.
    [Show full text]
  • Growth/Differentiation Factor 1 Alleviates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction
    Biochimica et Biophysica Acta 1842 (2014) 232–244 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbadis Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction Yan Zhang a,b,1, Xiao-Fei Zhang c,1,LuGaod,1,YuLiua,b, Ding-Sheng Jiang a,b,KeChenc, Qinglin Yang e, Guo-Chang Fan c,f, Xiao-Dong Zhang c, Congxin Huang a,b,⁎ a Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China b Cardiovascular Research Institute of Wuhan University, Wuhan 430060, China c College of Life Sciences, Wuhan University, Wuhan 430072, China d Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China e Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294-3360, USA f Departments of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA article info abstract Article history: Pathological cardiac hypertrophy is a major risk factor for developing heart failure, the leading cause of death in Received 12 June 2013 the world. Growth/differentiation factor 1 (GDF1), a transforming growth factor-β family member, is a regulator Received in revised form 15 November 2013 of cell growth and differentiation in both embryonic and adult tissues. Evidence from human and animal studies Accepted 17 November 2013 suggests that GDF1 may play an important role in cardiac physiology and pathology. However, a critical role for Available online 23 November 2013 GDF1 in cardiac remodelling has not been investigated.
    [Show full text]